Arkolith/Insider Trading/VNDA/Form 4

Moran Kevin Patrick

SVP, CFO & TreasurerVanda Pharmaceuticals Inc. (VNDA) · full profile →Form 4 · filed Aug 1, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$14K
Net Open-Market Flow
-$14K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 28, 2023Sell(S)2K$6.31$11K121K
Jul 28, 2023Sell(S)412$6.30$3K123K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-043990) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML